2297 — Rainmed Medical Income Statement
0.000.00%
Last trade - 00:00- HK$252.24m
- -HK$83.60m
- CNY73.22m
Annual income statement for Rainmed Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 6.1 | 81.2 | 83.6 | 73.2 |
| Cost of Revenue | ||||
| Gross Profit | 5.26 | 69 | 69.8 | 48.6 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 38.5 | 224 | 227 | 201 |
| Operating Profit | -32.4 | -143 | -143 | -128 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -151 | -639 | -1,351 | -117 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -145 | -634 | -1,346 | -117 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -145 | -634 | -1,346 | -116 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -145 | -634 | -1,346 | -116 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.124 | -0.531 | -1.48 | -0.099 |